<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F"><gtr:id>A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F</gtr:id><gtr:name>University of Guelph</gtr:name><gtr:address><gtr:line1>50 Stone Rd E</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F"><gtr:id>A1C1DFCB-DADF-4EE8-943E-004E34F3AB2F</gtr:id><gtr:name>University of Guelph</gtr:name><gtr:address><gtr:line1>50 Stone Rd E</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CD7853E3-B5AC-4FC9-B115-5B36DF2CFCE3"><gtr:id>CD7853E3-B5AC-4FC9-B115-5B36DF2CFCE3</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:otherNames>Charles Oliver</gtr:otherNames><gtr:surname>Nugent</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902087"><gtr:id>E9FBCF5B-954A-421F-B525-CE863CFB3F09</gtr:id><gtr:title>Structure, folding and evolution of alpha-helical transmembrane proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902087</gtr:grantReference><gtr:abstractText>Transmembrane (TM) proteins are involved in a wide range of important biological processes. Many are also prime drug targets - it has been estimated that over half of all drugs currently on the market target TM proteins. However, due to experimental difficulties, TM proteins are severely under-represented in structural databases. The biological and pharmacological importance of TM proteins highlights the need for accurate theoretical structure prediction methods for TM proteins to address this shortfall.

In the absence of structural data, bioinformatic strategies turn to sequence- based prediction methods. In this project, I will develop novel prediction tools which will assist with the two and three-dimensional modelling of TM proteins, detection of novel drug targets, and provide insight into TM protein function, assembly, evolution and aggregation. Collaboration with experimental groups working with TM proteins will provide opportunities to validate these methods.

This project has the potential to significantly enhance the accuracy of current TM protein models to the point where the application of medicinal chemistry becomes a reality. It may also provide fundamentally new insights of significant biological and biomedical relevance, while furthering our understanding of a wide range of diseases linked to TM proteins including diabetes, hypertension and epilepsy.</gtr:abstractText><gtr:technicalSummary>Transmembrane (TM) proteins are involved in a wide range of important biological processes such as cellular signalling, transport, communication and adhesion. Many are also prime drug targets - it has been estimated that over half of all drugs currently on the market target TM proteins. However, due to experimental difficulties, this class of protein is severely under-represented in structural databases, making up less than 2% of known structures in the PDB. The biological and pharmacological importance of TM proteins highlights the need for accurate theoretical structure prediction methods for TM proteins to address this shortfall.

In the absence of structural data, bioinformatic strategies turn to sequence- based prediction methods. In this project, I will develop novel prediction tools to aid the identification of structural features involved in pore formation and oligomeric interactions, which, when combined with my topology and helix packing tools, will allow prediction of TM protein quaternary structure for the first time. A genome scan for TM proteins containing pore-forming structures may lead to the identification of novel ion channels which represent an important class of targets for pharmaceutical intervention in a range of diseases including diabetes, hypertension and epilepsy.

An analysis of TM protein subunit interactions, combined with a systems biology approach, will also provide insight into TM protein evolution, quaternary structure symmetry and assembly pathways - areas where, compared to soluble proteins, relatively little is known. Additionally, I will analyse stoichiometry and symmetry, implicated in function and regulation, while furthering our understanding of protein aggregation within membranes which is linked to a plethora of clinical syndromes including Alzheimer?s and Parkinson?s disease.

By combining our novel prediction tools, I will adapt and optimise the FRAGFOLD ab initio method to predict TM protein three-dimensional sture. This will also involve the development of TM protein-specific energy functions and the use of molecular dynamics simulations in order to accurately assess model quality. Collaboration with NMR and X-ray crystallography groups will provide opportunities to validate our methods.

This project has the potential to significantly enhance the accuracy of current structural models of TM proteins, which today are largely restricted to two-dimensional topology maps. Recently we have modelled the Batten disease protein which has helped direct further experimental work into this incurable illness. With novel tools we hope to model such disease related proteins at higher resolutions to the point where the application of medicinal chemistry becomes a reality.</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-03-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>267440</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CASP10</gtr:description><gtr:id>910BD5E4-D78E-48B1-BB9C-D3AB83CAFE8B</gtr:id><gtr:impact>A paper which will appear in a special edition of the journal Proteins is in preparation.</gtr:impact><gtr:outcomeId>HmZSnPix36Q-1</gtr:outcomeId><gtr:partnerContribution>We have worked closely with the Prediction Centre and other assessors in order to collate all necessary data to assess the refinement category.</gtr:partnerContribution><gtr:piContribution>We have participated in CASP10 (Critical Assessment of Protein Structure Prediction) as assessors in the protein structure refinement category.

http://predictioncenter.org/</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Guelph</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Molecular and Cellular Biology</gtr:department><gtr:description>Collaboration with Lam Lab</gtr:description><gtr:id>434A1A3E-3950-43C0-9264-A9C40144446B</gtr:id><gtr:impact>Publication:
http://mbio.asm.org/content/4/5/e00678-13

Another is under review with Scientific Reports</gtr:impact><gtr:outcomeId>ZmHhCuoTMeH-1</gtr:outcomeId><gtr:partnerContribution>Experimental studies of the protein</gtr:partnerContribution><gtr:piContribution>Collaboration with Lam Lab, Department of Molecular and Cellular Biology, University of Guelph, Canada. Involved modelling of membrane protein target involved in o-antigen-subunit antiport across the bacterial inner membrane.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oxford Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D212DDD9-ECFC-4E93-9879-CCF3D84EBF2D</gtr:id><gtr:impact>Presented a seminar at University of Oxford Biochemistry department. Approximately 100 attendees from students to professor level.

We are now collaborating with Prof. Mark Sansom's group in the area of membrane protein refinement and molecular dynamics.</gtr:impact><gtr:outcomeId>rMu6v38Ka8X</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at ISMB 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>809746BE-6F6B-4CC2-9157-01ADA6C5EB22</gtr:id><gtr:impact>Special session at ISMB Berlin &amp;quot;Protein structure validation&amp;quot;, spoke about recent advances in membrane protein folding using predicted contacts (see 2012 PNAS paper). Attended by ~300 people.

Networking with a number of different groups, e.g. Debbie Marks at Harvard Medical School</gtr:impact><gtr:outcomeId>PJpWKPn8sHQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Birkbeck Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E9146B18-B269-4F4A-8D5D-52D95063F745</gtr:id><gtr:impact>Presented a seminar at UCL/Birkbeck Institute of Structural and Molecular Biology. Approximately 100 attendees from students to professor level.

None as yet.</gtr:impact><gtr:outcomeId>iuqfSB7KhWB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3B5E8B1E-821F-4315-B66E-33FBA9318BB2</gtr:id><gtr:title>Membrane protein orientation and refinement using a knowledge-based statistical potential.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb31d05d1bbe9388ebb9ea73c15ac0b"><gtr:id>bcb31d05d1bbe9388ebb9ea73c15ac0b</gtr:id><gtr:otherNames>Nugent T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>doi_16821_105_14_276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F409539-4322-4225-9EB6-034555FACA1D</gtr:id><gtr:title>Membrane protein structural bioinformatics.</gtr:title><gtr:parentPublicationTitle>Journal of structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb31d05d1bbe9388ebb9ea73c15ac0b"><gtr:id>bcb31d05d1bbe9388ebb9ea73c15ac0b</gtr:id><gtr:otherNames>Nugent T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1047-8477</gtr:issn><gtr:outcomeId>pm_16821_21_22075226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A813221-E0AE-4A00-A332-B48B8044D8E2</gtr:id><gtr:title>Accurate de novo structure prediction of large transmembrane protein domains using fragment-assembly and correlated mutation analysis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb31d05d1bbe9388ebb9ea73c15ac0b"><gtr:id>bcb31d05d1bbe9388ebb9ea73c15ac0b</gtr:id><gtr:otherNames>Nugent T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_16821_21_22645369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EB598D8-F542-48F2-A313-A046F7B2F399</gtr:id><gtr:title>Scalable web services for the PSIPRED Protein Analysis Workbench.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccda1d1d6582d0b4fe7096bc834aa32a"><gtr:id>ccda1d1d6582d0b4fe7096bc834aa32a</gtr:id><gtr:otherNames>Buchan DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>doi_16821_nar_gkt381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75868468-EE80-41FE-8B47-3859FFF4B155</gtr:id><gtr:title>Proton-dependent gating and proton uptake by Wzx support O-antigen-subunit antiport across the bacterial inner membrane.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33f006d87dd713b380dec7d11e2b96d0"><gtr:id>33f006d87dd713b380dec7d11e2b96d0</gtr:id><gtr:otherNames>Islam ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_16821_o_00678_13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>206C01A0-C0FD-4AF0-BFEE-A647B5C0FB03</gtr:id><gtr:title>Detecting pore-lining regions in transmembrane protein sequences.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb31d05d1bbe9388ebb9ea73c15ac0b"><gtr:id>bcb31d05d1bbe9388ebb9ea73c15ac0b</gtr:id><gtr:otherNames>Nugent T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>pm_16821_21_22805427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49E0A551-CCA1-4506-BF5E-43915D058F99</gtr:id><gtr:title>Evaluation of predictions in the CASP10 model refinement category.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb31d05d1bbe9388ebb9ea73c15ac0b"><gtr:id>bcb31d05d1bbe9388ebb9ea73c15ac0b</gtr:id><gtr:otherNames>Nugent T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn><gtr:outcomeId>doi_16821_prot_24377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C024AF17-7942-4781-80C2-92FB3576A33E</gtr:id><gtr:title>The MEMPACK alpha-helical transmembrane protein structure prediction server.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb31d05d1bbe9388ebb9ea73c15ac0b"><gtr:id>bcb31d05d1bbe9388ebb9ea73c15ac0b</gtr:id><gtr:otherNames>Nugent T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>pm_16821_21_21349872</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902087</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>